tirzepatide shortages Lilly's weight-loss drug removed from FDA's shortage list Mounjaro will remain off shortage

Use the icons at right to apply now

The medium-term outlook, assuming safety data remains reassuring, is very optimistic, with drug-effectiveness approaching that of obesity surgery, which remains the gold standard treatment in terms of effectiveness and value for money

Part of it is the anxiety of going through menopause itself, part of it is all the other things going on in your life at the same time (like career stress, aging parents, raising teens), and part of it is your dropping estrogen, which impacts neurotransmitters involved in mood regulation

Retatrutide is a 26-amino acid triple agonist that adds glucagon receptor activation to those two pathways

Its a pilot, not a permanent fix: the Bridge is scheduled to run through December 31, 2027, and what happens after that is still an open question

My current take on the subject is this: L-carnitine may modestly increase cardiovascular risk if taken over long periods of time